The effects of genistein as antiinflammatory and antiangiogenesis in primary endometriosis cell culture
Lab / animal
OA: diamond
CC0
⤵ 4 in-corpus citations
AI-generated summary
Genistein treatment of primary endometriosis cells reduced levels of IL-1β, TNF-α, IL-6, VEGF-A, and MMP-2 in a dose- and time-dependent manner compared to controls.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
To investigate whether genistein is anti-inflammation and anti-angiogenesis in endometriosis cells. Primary endometriosis cells were divided into seven groups, including control group and genistein-treatment group at dose 5 until 50 μmol/L. The times of incubation is 6, 24, and 48 hours. Levels of TNF-α, IL-6, IL-1β, MMP-2, and VEGF-A in supernatant cells were determined using the enzyme linked immunosorbent assay. The level of IL-1β was significantly lower in genistein-treatment at dose 20 until 50 μM compared to the control group (6 hours of treatment) (P<0.05). In 24 hours of treatment, the level of IL-1β was significantly lower in genistein-treatment start at all doses compared to control group (P <0.05). For 48 hours of incubation, the level of IL-1β was significantly lower in of genistein-treatment group at dose 10 until 50 μM than that to control group (P<0.05). The level of TNF-α and IL-6 were significantly decreased in genistein-treatment compared to control group in all duration of treatment (P<0.05). Level of VEGF-A were significantly lower in genistein-treatment at dose 20 until 50 μM compared to control group (P<0.05). The level of MMP-2 was significantly lower in the genistein-treatment at dose 10 and 30 μM compared to control group in 6 hours of treatment (P<0.05), at dose 10, 40, and 50 μM (24 hours of treatment), and all doses (48 hours of treatment). In conclusion, genistein act as anti-inflammatory and anti-angiogenesis in primary culture cells of endometriosis.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (36)
- Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis via openalex
- Activin-A is induced by interleukin-1β and tumor necrosis factor-α and enhances the mRNA expression of interleukin-6 and protease-activated receptor-2 and proliferation of stromal cells from endometrioma via openalex
- Autoimmune phenomena in infertile patients with endometriosis via openalex
- Changes in immunologic variables (TNF-a, sCD8 and sCD4) during danazol treatment in patients with endometriosis via openalex
- Effect of GnRH analogues on apoptosis and release of interleukin-1beta and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis via openalex
- Effect of soy isoflavones on endometriosis: interaction with estrogen receptor 2 gene polymorphism via openalex
- Epidemiology of endometriosis via openalex
- Estradiol and interleukin-1beta exert a synergistic stimulatory effect on the expression of the chemokine regulated upon activation, normal T cell expressed, and secreted in endometriotic cells via openalex
- Estrogen receptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis via openalex
- Estrogen receptor (ER) beta regulates ERalpha expression in stromal cells derived from ovarian endometriosis via openalex
- Genistein causes regression of endometriotic implants in the rat model via openalex
- Genistein does not affect vascularization and blood perfusion of endometriotic lesions and ovarian follicles in dorsal skinfold chambers of Syrian golden hamsters via openalex
- Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1beta via openalex
- Interleukin 1beta, interleukin-6, and tumor necrosis factor-alpha in endometriotic tissue and in endometrium via openalex
- Interleukin-1 stimulates macrophage migration inhibitory factor secretion in ectopic endometrial cells of women with endometriosis via openalex
- Interleukin-1β induces cyclooxygenase-2 expression and promotes the invasive ability of human mesenchymal stem cells derived from ovarian endometrioma via openalex
- Metformin suppresses interleukin (IL)-1beta-induced IL-8 production, aromatase activation, and proliferation of endometriotic stromal cells via openalex
- Pharmacologic, but not dietary, genistein supports endometriosis in a rat model via openalex
- Role of estrogen receptor-β in endometriosis via openalex
- The effect of second-line surgery on reproductive performance of women with recurrent endometriosis: a systematic review via openalex
- The epidemiology of endometriosis via openalex
- W6601488110 via openalex
- W1977671182 via openalex
- W1995784269 via openalex
- W2003389092 via openalex
- W2006762288 via openalex
- W2016509061 via openalex
- W2028712686 via openalex
- W2032737777 via openalex
- W2043760057 via openalex
- W2060108320 via openalex
- W2064891139 via openalex
- W2083701448 via openalex
- W2093303434 via openalex
- W2102835076 via openalex
- W2124864205 via openalex
Cited by (4)
- Genistein Effect on Estrogen Receptor especially Interleukin-6 and Tumor Necrosis Factor-α in Mice Model of Endometriosis: a Systematic Review and Meta-analysis 2023
- Pyrvinium pamoate induces in-vitro suppression of IL-6 and IL-8 produced by human endometriotic stromal cells 2020
- PENGARUH PEMBERIAN GENISTEIN TERHADAP PENURUNAN KADAR TNF ALPHA PADA ZALIR PERITONEAL MENCIT MODEL ENDOMETRIOSIS 2018
- The expression of vascular endothelial growth factor is affected by hypoxia inducible factor-1α in peritoneum of endometriosis mice treated with genistein 2016
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK